DNA polymorphisms in the 5'-flanking region of the human tissue kallikrein gene

Human Genetics

Volumn 99, Issue 6, 1997, Pages 727-734

  Song, Qing ^a   Chao, Julie ^a   Chao, Lee ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; KALLIKREIN;

ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; DNA FLANKING REGION; DNA POLYMORPHISM; DNA SEQUENCE; DNA TRANSFECTION; GENE DELETION; GENE FREQUENCY; HUMAN; HUMAN CELL; NEGRO; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CELL LINE; CHROMOSOME MAPPING; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE DELETION; HUMANS; KALLIKREINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; TISSUE KALLIKREINS;

EID: 0030913970     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050439     Document Type: Article

References (32)

1. Ader JL, Tran-Van T, Praddaude F (1986) Low urinary excretion of active and total kallikrein in young spontaneously hypertensive rats and effect of long-term angiotensin converting enzyme inhibition. J Hypertens 4 : 151-153
2. Ader JL, Tran-Van T, Praddaude F (1987) Renal tissue kallikrein in newborn and young SHR. Am J Hypertens 1 : 53S-55S
3. Angotti E, Mele E, Costanzo F, Avvedimento EV (1994) A polymorphism (G → A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. J Biol Chem 269 : 17371-17374
4. Bell GI, Karam JH, Rutter WWJ (1981) Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc Natl Acad Sci USA 78 : 5759-5763
5. Berge KE, Berg K (1991) A TaqI RFLP at the human renal kallikrein (KLK1) locus. Clin Genet 40 : 256
6. Berge KE, Berg K (1993) No effect of TaqI polymorphism at the human renal kallikrein (KLK1) locus on normal blood pressure level or variability. Clin Genet 44 : 196-202
7. Berry TD, Hasstedt SJ, Hunt SC, Wu LL, Smith JB, Ash O, Kuida H, Williams RR (1989) A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 13 : 3-8
8. Brown CJ, Baltz KA, Edenberg HJ (1992) Expression of the human ADH2 gene: an unusual Sp1-binding site in the promoter of a gene expressed at high levels in liver. Gene 121 : 313-320
9. Carretero OA, Scicli AG (1971) The renal kallikrein-kinin system in human and experimental essential hypertension. Clin Wochenschr 56 : 113-125
10. Carretero OA, Polomski C, Hampton A, Scicli AG (1976) Urinary kallikrein, plasma renin and aldosterone in New Zealand genetically hypertensive (GH) rats. Clin Exp Pharmacol Physiol 3 : 55-59
11. Carretero OA, Amin VM, Ocholik T, Scicli AG, Koch J (1978) Urinary kallikrein in rats bred for their susceptibility and resistance to the hypertensive effect of salt. Circ Res 42 : 727-731
12. Chao J, Chao L (1996) Functional analysis of human tissue kallikrein in transgenic mouse models. Hypertension 27 : 491-494
13. Cotton RG (1993) Current methods of mutation detection. Mutat Res 285 : 125-144
14. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268 : 10739-10745
15. Elliot R, Nuzum FR (1934) Urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology 18 : 462-414
16. Evans BA, Yun ZX, Close JA, Tregear GW, Kitamura N, Nakanishi S, Callen DF, Baker E, Hyland VJ, Sutherland GR, Richards RI (1988) Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry 27 : 3124-3129
17. Khoury MJ, Beaty TE, Cohen BE (1993) Fundamentals of genetic epidemiology. Oxford University Press, New York
18. Margolius HS, Geller RJ, Pisano JJ, Sjoerdsma A (1971) Altered urinary kallikrein excretion in human hypertension. Lancet 2 : 1063-1065
19. Margolius HS, Horwitz D, Pisano JJ, Keiser HR (1974) Urinary kallikrein in hypertension: relationship to sodium intake and sodium-retaining steroid. Circ Res 35 : 820-825
20. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF (1989) Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 17 : 2503-2516
21. Nichols WC, Liepnieks JJ, McKusick VA, Benson MD (1989) Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allelespecific enzymatic amplification. Genomics 5 : 535-540
22. Okayama H, Curiel DT, Brandy ML, Holmes MD, Crystal RG (1989) Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med 114 : 105-113
23. Pravence M, Ken V, Kunes J, Scicli AG, Carretero OA, Simonet L, Kurtz TW (1991) Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension 17 : 242-246
24. Richards RI, Holman K, Shen Y, Kozman H, Harley H, Brook D, Shaw D (1991) Human glandular kallikrein genes: genetic and physical mapping of the KLK1 locus using a highly polymorphic microsatellite PCR marker. Genomics 11 : 77-82
25. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
26. Sarkar G, Yoon HS, Sommer SS (1992) Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP. Nucleic Acids Res 20 : 871-878
27. Sommer SS, Cassady JD, Sobell JL, Bottema CD (1989) A novel method for detecting point mutations or polymorphisms and its application to population screening for carriers of phenylketonuria. Mayo Clin Proc 64 : 1361-1372
28. Song Q, Chao J, Chao L (1996) Liver-targeted expression of human tissue kallikrein induces hypotension in transgenic mice. Clion Exp Hypertens (in press)
29. Wang J, Xiong W, Yang Z, Davis T, Dewey MJ, Chao J, Chao L (1994) Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 23 : 236-243
30. Williams RR, Hunt SC, Hasstedt SJ, Wu LL, Barlow GK, Stults BM, Ash KO, Kuida H (1987) Early pathogenesis of primary hypertension: biological markers of genetically predisposed hypertension. Elsevier Science Publishing, Amsterdam
31. Woodley-Miller CM, Chao J, Chao L (1989) Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probes. J Hypertens 7 : 865-871
32. Wu DY, Ugozzoli L, Pal BK, Wallace RB (1989) Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci USA 86 : 2757-2760